20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amorosi, CJ; Dunham, MJ; Fowler, DM; Gallis, B; Kowalski, JP; McDonald, MG; Nath, A; Paco, L; Ray, S; Rettie, AE; Sitko, KA; Totah, RA | 1 |
Achyut, BR; Angara, K; Arbab, AS; Borin, TF; Rashid, MH | 1 |
1 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Breast Neoplasms
Article | Year |
---|---|
Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis.
Topics: Arachidonic Acid; Breast Neoplasms; Cytochrome P450 Family 4; Female; Humans; Hydroxyeicosatetraenoic Acids; Molecular Targeted Therapy; Neoplasm Metastasis; Signal Transduction; Tumor Microenvironment | 2017 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Breast Neoplasms
Article | Year |
---|---|
Expression and Functional Characterization of Breast Cancer-Associated Cytochrome P450 4Z1 in
Topics: Amidines; Breast Neoplasms; Cytochrome P450 Family 4; Disease Progression; Humans; Hydroxyeicosatetraenoic Acids; Hydroxylation; Interleukin-1 Receptor-Associated Kinases; Lauric Acids; Mass Spectrometry; Microsomes, Liver; Molecular Docking Simulation; Oxidation-Reduction; Recombinant Proteins; Saccharomyces cerevisiae | 2017 |